[XENE] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
08-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- 53.44%
YoY- 50.05%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 6,000 0 0 0 16 264 15 5269.91%
PBT -8,558 -14,383 -7,801 -3,755 -8,065 -7,742 -7,380 10.34%
Tax 357 678 200 159 14 -902 -513 -
NP -8,558 -14,383 -7,801 -3,755 -8,065 -7,742 -7,380 10.34%
Tax Rate - - - - - - - -
Total Cost 14,558 14,383 7,801 3,755 8,081 8,006 7,395 56.88%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin -142.63 0.00 0.00 0.00 -50,406.25 -2,932.58 -49,200.00 -97.94%
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS -0.34 -0.71 -0.55 -0.22 -0.45 -0.43 -0.41 -11.70%
EPS Diluted -0.33 -0.71 -0.55 -0.21 -0.45 -0.43 -0.41 -13.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.